tiprankstipranks
Advertisement
Advertisement

GOSS Stock Latest News

Vanguard Total Stock Market (VTI) ETF Daily Update — June 16, 2026
Market NewsVanguard Total Stock Market (VTI) ETF Daily Update — June 16, 2026
20h ago
VTI
AAPL
Gossamer Bio shareholders reaffirm board and governance structure
PremiumCompany Announcements
Gossamer Bio shareholders reaffirm board and governance structure
12d ago
8K
GOSS
Gossamer Bio Restructures Capital Through Convertible Notes Exchange
PremiumCompany Announcements
Gossamer Bio Restructures Capital Through Convertible Notes Exchange
12d ago
8K
GOSS
Gossamer Bio announces early tender results, early settlement of solicitation
PremiumThe Fly
Gossamer Bio announces early tender results, early settlement of solicitation
14d ago
GOSS
Gossamer Bio announces extension of early tender date for exchange offer
PremiumThe Fly
Gossamer Bio announces extension of early tender date for exchange offer
15d ago
GOSS
Gossamer Bio Extends Early Deadline in Note Exchange
PremiumCompany AnnouncementsGossamer Bio Extends Early Deadline in Note Exchange
15d ago
8K
GOSS
Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/29/26?
Premium
Market News
Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/29/26?
19d ago
VTI
AAPL
Investors Sue Gossamer Bio (GOSS) Over Inflated High Blood Pressure Study Claims
Premium
Market News
Investors Sue Gossamer Bio (GOSS) Over Inflated High Blood Pressure Study Claims
19d ago
GOSS
Why Is Vanguard Total Stock Market ETF (VTI) Rising Today, 5/28/26?
PremiumMarket News
Why Is Vanguard Total Stock Market ETF (VTI) Rising Today, 5/28/26?
20d ago
VTI
AAPL
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 5/27/26?
PremiumMarket News
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 5/27/26?
21d ago
MU
ZS
Buy Rating Reiterated on Gossamer Bio as NDA Path De-Risks; $5 Price Target Maintained
PremiumRatings
Buy Rating Reiterated on Gossamer Bio as NDA Path De-Risks; $5 Price Target Maintained
22d ago
GOSS
Goldman Sachs suspends rating on Gossamer Bio
PremiumThe Fly
Goldman Sachs suspends rating on Gossamer Bio
28d ago
GOSS
Gossamer Bio Balances Seralutinib Promise With Cash Strain
PremiumCompany AnnouncementsGossamer Bio Balances Seralutinib Promise With Cash Strain
28d ago
GOSS
Gossamer Bio price target lowered to 28c from 30c at Barclays
Premium
The Fly
Gossamer Bio price target lowered to 28c from 30c at Barclays
29d ago
GOSS
Midday Fly By: Dominion to combine with NextEra, Publicis to acquire LiveRamp
Premium
The Fly
Midday Fly By: Dominion to combine with NextEra, Publicis to acquire LiveRamp
30d ago
D
F
Morning Movers: LiveRamp jumps following pact to be acquired by Publicis
PremiumThe Fly
Morning Movers: LiveRamp jumps following pact to be acquired by Publicis
30d ago
D
F
Gossamer Bio Restructures Debt and Advances Seralutinib Program
PremiumCompany Announcements
Gossamer Bio Restructures Debt and Advances Seralutinib Program
30d ago
8K
GOSS
Gossamer Bio launches exchange offer, consent solicitation
PremiumThe Fly
Gossamer Bio launches exchange offer, consent solicitation
30d ago
GOSS
Gossamer Bio reports Q1 EPS (20c) vs. (16c) last year
PremiumThe Fly
Gossamer Bio reports Q1 EPS (20c) vs. (16c) last year
30d ago
GOSS
Gossamer Bio sees cash runway into 1Q27
PremiumThe FlyGossamer Bio sees cash runway into 1Q27
30d ago
GOSS
Options Volatility and Implied Earnings Moves Today, May 18, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, May 18, 2026
30d ago
NIU
BIDU
Gossamer Bio Investors File Securities Lawsuit Over Alleged Misstatements About Phase 3 Drug Trial 
Premium
Class Action
Gossamer Bio Investors File Securities Lawsuit Over Alleged Misstatements About Phase 3 Drug Trial 
2M ago
GOSS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >